Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DNASENSE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.2% 1.2%   Bankruptcy risk   1.7% 1.5% 16.4% 8.0% 3.5% 2.3% 11.4% 11.4%   Credit score (0-100)   74 77 11 29 53 64 21 21   Credit rating   A A BB BB BBB BBB BB BB   Credit limit (kDKK)   1.6 8.5 -0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,364 3,380 1,446 3,041 4,201 4,533 0.0 0.0   EBITDA   676 878 -1,368 126 1,132 852 0.0 0.0   EBIT   676 878 -1,368 126 1,132 791 0.0 0.0   Pre-tax profit (PTP)   672.4 870.6 -1,382.2 102.2 1,114.1 764.6 0.0 0.0   Net earnings   524.1 678.6 -1,081.6 77.9 866.9 549.8 0.0 0.0   Pre-tax profit without non-rec. items   672 871 -1,382 102 1,114 765 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 183 286 0.0 0.0   Shareholders equity total   910 1,289 -92.9 -15.0 852 802 752 752   Interest-bearing liabilities   0.0 0.0 0.0 106 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,597 2,073 871 1,231 2,835 2,219 752 752   Net Debt   -958 -1,272 -108 106 -107 -328 -752 -752     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,364 3,380 1,446 3,041 4,201 4,533 0.0 0.0   Gross profit growth   31.6% 43.0% -57.2% 110.3% 38.1% 7.9% -100.0% 0.0%   Employees   2 4 5 5 6 7 0 0   Employee growth %   100.0% 100.0% 25.0% 0.0% 20.0% 16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,597 2,073 871 1,231 2,835 2,219 752 752   Balance sheet change%   34.8% 29.8% -58.0% 41.4% 130.4% -21.7% -66.1% 0.0%   Added value   676.3 877.6 -1,367.8 126.1 1,131.7 851.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 183 42 -286 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   28.6% 26.0% -94.6% 4.1% 26.9% 17.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   48.6% 47.9% -90.1% 11.4% 55.9% 31.4% 0.0% 0.0%   ROI %   75.3% 79.9% -174.2% 31.3% 137.5% 71.3% 0.0% 0.0%   ROE %   58.4% 61.7% -100.2% 7.4% 83.2% 66.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   57.0% 62.2% -10.3% -1.2% 37.8% 37.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -141.7% -144.9% 7.9% 84.4% -9.5% -38.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% -711.1% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 45.1% 49.4% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   2.8 3.2 1.4 1.5 2.3 2.0 0.0 0.0   Current Ratio   2.8 3.2 1.3 1.5 1.5 1.8 0.0 0.0   Cash and cash equivalent   958.5 1,271.9 108.3 0.0 107.0 328.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,012.8 1,424.9 177.0 381.0 923.3 867.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   338 219 -274 25 189 122 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   338 219 -274 25 189 122 0 0   EBIT / employee   338 219 -274 25 189 113 0 0   Net earnings / employee   262 170 -216 16 144 79 0 0